Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic
about
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicMolecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern AlaskaProspective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureusMinocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic ReviewSkin and soft-tissue infections in suburban primary care: epidemiology of methicillin-resistant Staphylococcus aureus and observations on abscess management.Antibacterials as adjuncts to incision and drainage for adults with purulent methicillin-resistant Staphylococcus aureus (MRSA) skin infections.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control studyTrimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus: a forgotten alternative?Methicillin-resistant Staphylococcus aureus in HIV-infected patients.Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unitEfficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares.Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) studyTreatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycinMRSA Infections in HIV-Infected People Are Associated with Decreased MRSA-Specific Th1 Immunity.Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.Trends in prescribing beta-lactam antibiotics for treatment of community-associated methicillin-resistant Staphylococcus aureus infectionsCommunity-associated meticillin-resistant Staphylococcus aureusTrimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin AbscessRole of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community.Antibiotic resistance in Staphylococcus aureus-containing cutaneous abscesses of patients with HIV.Ceftobiprole: a new broad spectrum cephalosporin.Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis.Methicillin-resistant Staphylococcus aureus: a community health threat.Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature.Antibiotic overuse and resistance in dermatology.Community-Associated Methicillin-Resistant Staphylococcus aureus in the Pediatric Population.New and emerging concepts in managing and preventing community-associated methicillin-resistant Staphylococcus aureus infections.MRSA in Croatia: prevalence and management.Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus.Treatment of Staphylococcus aureus Infections.Crystallization and preliminary X-ray analysis of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.Subgroup Analysis of Antibiotic Treatment for Skin Abscesses.Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.[Determination of associated antimicrobial resistance in clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa in a public hospital in Goiânia, State of Goiás].Purulent skin and soft tissue infection: antibiotic selection in the community.Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial.Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
P2860
Q24614464-E2119912-359D-47A8-8D91-2D2F0D027323Q24645571-B29B99FC-01AF-41A1-A814-4FC12D03148BQ24678579-422A4A30-0C13-4112-9085-C7849184B324Q26771470-C0FC3B56-B760-47A1-BCD9-043F12BA32D3Q30998878-300F21D5-0E1D-4094-A439-A03913C7D6F9Q34153675-3C7FDEB5-1C68-4E22-A8ED-F325962777A7Q34157657-E667B136-AB1C-41C9-8BB0-F67ECB2F92F5Q34281438-41B4EEE9-281C-4E9C-B932-06B95A158F32Q34979705-0EEBA899-F017-4AA6-B9AA-DB0D079B07CAQ35026548-F4944D3F-1E8B-4DAD-B6AD-288AA1A03121Q35029581-38291344-FD61-4863-974D-FB74B6FF44E7Q35385754-3D25BD30-E430-492F-8B4D-5BC2FFA6B3D2Q35671893-8E95AC83-9A5B-4172-871A-940BEDF25D4BQ35959558-1B87E1A0-CFDC-4ECC-AD0A-87B456DBE2EAQ35993709-5098D4A7-4204-4DAA-ACED-7857FA0FE94AQ36094861-6236BF29-BF19-4614-A599-E59C2C9A513DQ36314569-96DD7C1E-C382-4AC4-9B45-E6C7B164B798Q36438720-4928E959-991A-42E0-A104-1406166FD785Q36852033-7B87DCBF-963D-4A77-9DCC-045BAAB34A48Q37058032-7C5AD76B-D40E-4DC7-8F50-B075FB725A6FQ37109817-D97DED00-3B0B-4D0E-B3A8-59C047B7F659Q37345178-85AC71FF-510A-49DA-9D90-97CB23E9E14EQ37519733-AD3EEECA-7BAB-417E-8C74-2417F3CA725EQ37637758-EACB724A-D44D-4F66-8582-2C6E330404C0Q37810406-2EC2538D-8C25-4CC7-93B0-43680948341BQ37819539-58AB4C4D-D5A3-48DE-87CB-D0ED49CC16F8Q37978658-720A1622-3A3E-4D12-A0FB-F70F8756C29AQ38010519-BA0DB518-2B20-4D54-BDD6-CC8BE803624EQ38051319-0AE0C830-D639-4A89-BB4B-345A61B836BEQ38558047-0E634639-5D43-4753-B754-14B74A1C907EQ38631043-D3FD9ABA-DE13-4F12-B5AA-8ACB16F9E672Q40014144-8A429455-F92F-4E6F-80F4-BBE905F46DD3Q40049973-83B232BF-942B-420F-B6B8-047D34A55923Q40369763-50518ACF-ADA4-41A6-A082-B8743DD0A25FQ41927713-3CD0641C-7ED1-4334-8D58-5C5BABE96070Q42037140-0B196E4F-080B-4E4E-B615-3B89608E72E0Q43267359-EA813410-358B-45DA-9B52-2B75F5304D2CQ44186610-FC0F3D33-971B-438C-BDC9-5BC58A4DAE07Q45247343-559A2034-F321-48A6-B7FC-9084BFE83844Q46274310-185BA9FB-8394-4319-9A59-37B6973845BA
P2860
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Treatment and outcomes of infe ...... aureus at an ambulatory clinic
@ast
Treatment and outcomes of infe ...... aureus at an ambulatory clinic
@en
Treatment and outcomes of infe ...... ureus at an ambulatory clinic.
@nl
type
label
Treatment and outcomes of infe ...... aureus at an ambulatory clinic
@ast
Treatment and outcomes of infe ...... aureus at an ambulatory clinic
@en
Treatment and outcomes of infe ...... ureus at an ambulatory clinic.
@nl
prefLabel
Treatment and outcomes of infe ...... aureus at an ambulatory clinic
@ast
Treatment and outcomes of infe ...... aureus at an ambulatory clinic
@en
Treatment and outcomes of infe ...... ureus at an ambulatory clinic.
@nl
P2093
P2860
P356
P1476
Treatment and outcomes of infe ...... aureus at an ambulatory clinic
@en
P2093
Daniel E Cohen
Fumihide Kanaya
John D Szumowski
Kenneth H Mayer
P2860
P304
P356
10.1128/AAC.01244-06
P407
P577
2006-11-20T00:00:00Z